Jim Jinn-Chyuan Sheu Selected Research

Jim Jinn-Chyuan Sheu Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 12/2007
9	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 12/2007
7	Endometriosis 01/2022 - 02/2011
6	Squamous Cell Carcinoma of Head and Neck 10/2020 - 03/2009
6	Carcinoma (Carcinomatosis) 01/2020 - 12/2007
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2021 - 01/2020
4	Carcinogenesis 12/2020 - 08/2008
4	Mouth Neoplasms (Oral Cancer) 01/2019 - 03/2009
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2021 - 08/2020
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2011 - 10/2008
2	Breast Neoplasms (Breast Cancer) 02/2022 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2019
2	Infertility (Sterility) 08/2015 - 03/2012
2	Infections 10/2011 - 09/2011
1	Inflammation (Inflammations) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Serous Cystadenocarcinoma 12/2016
1	Prostatic Neoplasms (Prostate Cancer) 04/2013
1	Fibrosis (Cirrhosis) 11/2011
1	Hepatitis B 05/2011
1	Genomic Instability 12/2010
1	Disease Progression 07/2010
1	Myopia 01/2009
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2009
1	Asthma (Bronchial Asthma) 01/2009
1	Multiple Sclerosis 10/2008
1	Exanthema (Rash) 10/2008
1	Rheumatoid Arthritis 10/2008
1	Autoimmune Diseases (Autoimmune Disease) 10/2008
1	Epstein-Barr Virus Infections 08/2008

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2007
5	Pharmaceutical PreparationsIBA 01/2022 - 09/2011
5	Biological ProductsIBA 01/2022 - 12/2007
5	Messenger RNA (mRNA)IBA 01/2022 - 02/2017
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2010
4	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 08/2008
3	Transcription Factors (Transcription Factor)IBA 10/2020 - 02/2017
3	MicroRNAs (MicroRNA)IBA 12/2016 - 01/2013
3	AntigensIBA 08/2015 - 12/2007
2	RNA Polymerase I (Polymerase I, RNA)IBA 01/2022 - 11/2016
2	ParaffinIBA 06/2021 - 12/2020
2	Cadherins (E-Cadherin)IBA 12/2020 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 10/2020 - 03/2009
2	Tumor Biomarkers (Tumor Markers)IBA 01/2020 - 07/2010
2	FlavonoidsIBA 01/2017 - 09/2011
2	MucinsIBA 08/2015 - 03/2012
2	ChromatinIBA 03/2013 - 09/2012
1	GelatinIBA 02/2022
1	Thrombin FDA Link 02/2022
1	Hemostatics (Antihemorrhagics)IBA 02/2022
1	CX 5461IBA 01/2022
1	omipalisibIBA 01/2022
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 06/2021
1	Long Noncoding RNAIBA 01/2021
1	Ubiquitin-Conjugating EnzymesIBA 12/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2020
1	Deoxyglucose (2 Deoxy D glucose)IBA 08/2020
1	squamous cell carcinoma-related antigenIBA 08/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Radiation-Sensitizing AgentsIBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	Keratins (Keratin)IBA 01/2019
1	CateninsIBA 01/2017
1	ApigeninIBA 01/2017
1	Ribosomal Proteins (Ribosomal Protein)IBA 11/2016
1	isochaihulactoneIBA 04/2013
1	Androgen Receptors (Androgen Receptor)IBA 04/2013
1	AndrogensIBA 04/2013
1	CyclinsIBA 03/2013
1	Adenosine Triphosphatases (ATPase)IBA 09/2012
1	Adenosine Triphosphate (ATP)IBA 09/2012
1	Glucose (Dextrose)FDA LinkGeneric 03/2012
1	butylidenephthalideIBA 02/2012
1	LumicanIBA 11/2011
1	Cytotoxins (Cytolysins)IBA 10/2011
1	Type IV Secretion SystemsIBA 10/2011
1	CholesterolIBA 10/2011
1	6,7-dihydroxyflavoneIBA 09/2011
1	hesperetinIBA 09/2011
1	RNA (Ribonucleic Acid)IBA 09/2011
1	QuercetinIBA 09/2011
1	kaempferolIBA 09/2011
1	HesperidinIBA 09/2011
1	Mucin-4IBA 02/2011
1	HaptoglobinsIBA 07/2010
1	Arecoline (Arecolin)IBA 07/2010
1	Drinking WaterIBA 07/2010
1	RTKI cpdIBA 03/2009
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2009
1	Phosphotransferases (Kinase)IBA 01/2009
1	Interleukin-18 (Interleukin 18)IBA 01/2009
1	CytokinesIBA 10/2008
1	Interleukin-2 (IL2)IBA 10/2008
1	Antinuclear AntibodiesIBA 10/2008
1	SodiumIBA 08/2008

Therapy/Procedure

9	Therapeutics 12/2020 - 12/2007
1	Radiotherapy 01/2020
1	Immunotherapy 04/2010